Skip to content
AkademScholar

Products

For developers

AkademBasesoonDeveloper API
Journal

Clinical Lymphoma Myeloma & Leukemia

ISSN:
2152-2650
0
h-index
0
Citations
26
Works
0.00
2-year mean citedness

Trust signals

1 of 3 signals present

Independent positive signals — not a single “predatory/legitimate” verdict, but a converging picture.

  • DOAJ
    No data
    doaj.org
  • OAK list
    No data
    OAK
  • Valid ISSN
    Present
    ISSN

This is an information label, not an official ruling. A missing signal is not a penalty — a regional journal may simply not be in DOAJ.

Trends over time

Performance over time

Citation overview

Publications (bars) and citations (line) by year

  • Publications
  • Citations
03581001201920212023202420252019: Publications 1, Citations 02021: Publications 2, Citations 02023: Publications 10, Citations 02024: Publications 5, Citations 02025: Publications 8, Citations 0

Publication history

035810201920212023202420252019: Publications 12021: Publications 22023: Publications 102024: Publications 52025: Publications 8

h-index evolution

Cumulative h-index by year

01201920212023202420252019: h-index 02021: h-index 02023: h-index 02024: h-index 02025: h-index 0

Most-cited works

  1. The Clinical Efficacy of Chelation Therapy in Patients with Myelodysplastic Syndrome, Low Risk20190 citations
  2. MDS-259: Myelodysplastic Syndrome in Uzbekistan: A Study of Prevalence20210 citations
  3. Poster: MDS-259: Myelodysplastic Syndrome in Uzbekistan: A Study of Prevalence20210 citations
  4. CML-491 Case Report of Variant Translocations and Atypical BCR::ABL Transcripts in CML Management20230 citations
  5. POSTER: CML-491 Case Report of Variant Translocations and Atypical BCR::ABL Transcripts in CML Management20230 citations
  6. POSTER: CML-449 JAK2-Unmutated Erythrocytosis in Chronic Phase Myeloid Leukemia (CP-CML) During Tyrosine Kinase Inhibitor (TKI) Treatment20230 citations
  7. POSTER: ALL-253 Evaluation of Aberrant Expression of CD Markers in Acute Leukemia Cells20230 citations
  8. POSTER: CML-319 Molecular Response of ≤10% BCR::ABL1IS Is Predictive of Positive Outcomes in Patients With Treatment-Resistant Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Treated With Ponatinib From the Phase 2 OPTIC Trial20230 citations
  9. MDS-580 Case Report of Myelodysplastic Neoplasm (MDS) Hiding Under Immune Thrombocytopenic Purpura (ITP)20230 citations
  10. POSTER: ALL-296 Results of Treatment of Children With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia With Low-dose Chemotherapy Without Bone Marrow Transplantation in Uzbekistan20230 citations
View in AkademIndex →